Cargando…

Induction and Prevention of Gastric Cancer with Combined Helicobacter Pylori and Capsaicin Administration and DFMO Treatment, Respectively

Gastric cancer risk evolves over time due to environmental, dietary, and lifestyle changes, including Helicobacter pylori (H. pylori) infection and consumption of hot peppers (i.e., capsaicin). H. pylori infection promotes gastric mucosal injury in the early phase of capsaicin exposure. This relatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aziz, Faisal, Xin, Mingxia, Gao, Yunfeng, Chakroborty, Abhijit, Khan, Imran, Monts, Josh, Monson, Kjersten, Bode, Ann M., Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226438/ https://www.ncbi.nlm.nih.gov/pubmed/32231118 http://dx.doi.org/10.3390/cancers12040816

Ejemplares similares

Relevance of miR-223 as Potential Diagnostic and Prognostic Markers in Cancer †
por: Aziz, Faisal, et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) and Neuroblastoma: A Review
por: Tangella, Adarsh Vardhan, et al.
Publicado: (2023)

Maintenance DFMO Increases Survival in High Risk Neuroblastoma
por: Sholler, Giselle L. Saulnier, et al.
Publicado: (2018)

Estrogen-related receptor alpha directly binds to p53 and cooperatively controls colon cancer growth through the regulation of mitochondrial biogenesis and function
por: De Vitto, Humberto, et al.
Publicado: (2020)

Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
por: Ayoola, Moses B., et al.
Publicado: (2022)

Difluoromethylornithine (DFMO) Enhances the Cytotoxicity of PARP Inhibition in Ovarian Cancer Cells
por: El Naggar, Olivia, et al.
Publicado: (2022)

MDB-03. DFMO AS A TREATMENT STRATEGY IN GROUP 3 MEDULLOBLASTOMA
por: Shahab, Shubin, et al.
Publicado: (2023)

Anti-GD2 induced allodynia in rats can be reduced by pretreatment with DFMO
por: Diccianni, Mitchell B., et al.
Publicado: (2020)

ETMR-18. TARGETING Lin28 IN ETMR WITH ODC1 INHIBITOR DFMO
por: Goodyke, Austin, et al.
Publicado: (2020)

Induction and Regulation of the Innate Immune Response in Helicobacter pylori Infection
por: Gobert, Alain P., et al.
Publicado: (2022)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Structural Insight into DFMO Resistant Ornithine Decarboxylase from Entamoeba histolytica: An Inkling to Adaptive Evolution
por: Preeti,, et al.
Publicado: (2013)

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
por: Saulnier Sholler, Giselle L., et al.
Publicado: (2015)

CLRM-14 INTRATUMORAL EXTRACELLULAR METABOLIC IMPACT OF DFMO AND AMXT 1501 IN LIVE HUMAN GLIOMAS
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2022)

Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats
por: Madka, Venkateshwar, et al.
Publicado: (2023)

ALOPECIA AREATA IS NOT ASSOCIATED WITH HELICOBACTER PYLORI
por: Abdel Hafez, Hisham Zayan, et al.
Publicado: (2009)

Evodiamine Inhibits Helicobacter pylori Growth and Helicobacter pylori-Induced Inflammation
por: Yang, Ji Yeong, et al.
Publicado: (2021)

Helicobacter pylori : revisión bibliográfica
por: Gómez Morayta, Enrique
Publicado: (2003)

Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study
por: Alber, Jessica, et al.
Publicado: (2018)

DFMO Improves Survival and Increases Immune Cell Infiltration in Association with MYC Downregulation in the Pancreatic Tumor Microenvironment
por: Nakkina, Sai Preethi, et al.
Publicado: (2021)

Helicobacter pylori and hormones.
por: Calam, J.
Publicado: (1996)

Helicobacter pylori and dyspepsia.
por: Talley, N. J.
Publicado: (1999)

Helicobacter pylori and apoptosis.
por: Moss, S. F.
Publicado: (1998)

Transmission of Helicobacter pylori
por: Axon, Anthony T. R.
Publicado: (1997)

Management of Helicobacter pylori
por: Shiota, Seiji, et al.
Publicado: (2010)

Helicobacter pylori Infection
por: Hsu, Ping-I, et al.
Publicado: (2015)

Helicobacter pylori and Pathogenesis
por: Tomoda, Akio, et al.
Publicado: (2015)

Bacteriophages of Helicobacter pylori
por: Muñoz, Angela B., et al.
Publicado: (2020)

Epigenetics and Helicobacter pylori
por: Capparelli, Rosanna, et al.
Publicado: (2022)

Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: A mini review
por: Graham, David Y., et al.
Publicado: (2018)

Helicobacter pylori: a poor man's gut pathogen?
por: Khalifa, Mohammed Mahdy, et al.
Publicado: (2010)

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas
por: Zell, Jason A., et al.
Publicado: (2012)

DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27(Kip1) activity in neuroblastoma
por: KOOMOA, DANA-LYNN T., et al.
Publicado: (2013)

Evaluation of Susceptibility of the Human Pathogen Helicobacter pylori to the Antibiotic Capreomycin
por: Sukati, Suriyan, et al.
Publicado: (2022)

Relationship between Helicobacter pylori and idiopathic chronic urticaria: effectiveness of Helicobacter pylori eradication
por: Mogaddam, Majid Rostami, et al.
Publicado: (2015)

Thin Layer Immunoassay: An Economical Approach to Diagnose Helicobacter pylori Infection in Gastroduodenal Ulcer Disease Patients of Pakistan, a Comparative Analysis
por: Aziz, Faisal, et al.
Publicado: (2023)

Role of non-Helicobacter pylori gastric Helicobacters in helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma
por: Lemos, Fabian Fellipe Bueno, et al.
Publicado: (2023)

Helicobacter pylori: therapeutic targets.
por: Louw, J. A., et al.
Publicado: (1998)

Pathobiology of Helicobacter pylori infection.
por: Cave, D. R., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_aas2rlln3233o4hb6vhalrppd0